Pain Management

In an attempt to provide the best and most up to date care to our patients, our clinical activities are complemented with a variety of research trials.
The following studies are currently open to enrollment at the NYU Pain Management Center:

• “A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Intravenous Methylnaltrexone (MOA-728) for the Treatment of  Postoperative Ileus after Ventral Hernia Repair”
• “Phase I Study of Treatment Patterns for Non-surgical Acute Pain”
• “A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study with an Open-Label Run-in to Assess the Efficacy, Tolerability, and Safety of BTDS 10 or BTDS 20 Compared to Placebo in Opioid-Naïve Subjects with Moderate to Severe Chronic Low Back Pain” (BUP 3024)
•  “A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of the Efficacy and Safety of Lubiprostone in Patients with Opioid Induced Bowel Dysfunction” (SPI/0211OBD-0632)
•  “A Randomized, Double-Blind, Parallel-Group Study of Cardiovascular Safety in Osteoarthritis or Rheumatoid Arthritis Patients with or at High Risk for Cardiovascular Disease Comparing Celecoxib With Naproxen and Ibuprofen” (A3191172 - PRECISION)
• “A Multicenter, Placebo-Controlled, Double Blind, Two-Phase Crossover Study of Nasalfent (Fentanyl Citrate Nasal Spray) in The Treatment of Breakthrough Cancer Pain (BTCP) in Subjects Taking Regular Opioid Therapy” (CP043)
• “An Open-Label Study Investigating Long-Term Safety and Tolerability of NasalFent (Fentanyl Citrate Nasal Spray) in The Treatment of Breakthrough Cancer Pain (BTCP) in Subjects Taking Regular Opioid Therapy” (CP045)
• “A Multiple-Dose, Non-Randomized, Open-Label, Multicenter Study to Evaluate the Long-Term Safety and Effectiveness of EN3267 in the Treatment of Breakthrough Pain in Cancer Patients” (EN3267-007)
• “Spinal Cord Stimulation in Chronic Intractable Pelvic Pain: A Comparison of Lead Placement Techniques”
• “A Randomized, Controlled Evaluation of a New Muscle Pain Detection Device (MPDD) to Diagnose Muscle Pain in Back or Neck Pain Patients”
• “Magnetoencephalographic Studies of Neurologic and Psychiatric Patients” (Thalamocortical Dysrrhythmia Syndrome in CRPS Patients)

Patients with the following conditions could qualify for some of our studies:

• Pain caused by cancer or by cancer treatment
• Chronic constipation caused by the use of opioid medications (like morphine, methadone, fentanyl…)
• Muscle Pain
• Osteoarthritis
• Rheumatoid Arthritis
• Chronic Low Back Pain
• Chronic Pelvic Pain
• Complex Regional Pain Syndrome (CRPS) or Regional Sympathetic Dystrophy (RSD)
• Planning Surgery for Ventral Hernia

If you are interested in participating in any of our studies, please contact us at painresearch@med.nyu.edu or at phone (212) 263-7935. 
We’ll be happy to give you more information and to evaluate your eligibility to enrollment.